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With the increasing presence of paramedics 
as healthcare providers, many times as the sole 
medical provider in remote areas,[1] on offshore 
facilities, humanitarian missions, remote oil 
and gas facilities,[2,3] and as medics in close 
protection teams in high-risk areas, as well as 
at large scale gatherings that carry a history 
and an increased risk of disease outbreaks [4], 
the need for non-traditional, specialised educa-
tion is becoming increasingly apparent. One 
specialty area of medical practice not commonly 
addressed in traditional paramedic education is 
that of tropical diseases and tropical medicine.
While a paramedic working in most Western 
countries is unlikely to encounter these condi-
tions regularly in clinical practice, there are 
now situations where members of the increas-
ingly globally-mobile paramedic workforce may 
find themselves facing these case presentations. 
Presented here is a brief overview of major 
tropical diseases for paramedics, including the 
big three (malaria, HIV/AIDS and tuberculo-
sis), as well as cholera, yellow fever and tetanus, 
along with treatment recommendations. We 
have previously discussed Zika Virus Disease in 
detail, and we will discuss the neglected tropical 
diseases (NTDs) in a future article. As always, 
up-to-date medical reference material and local 
clinical guidelines should be followed in all 
cases where medical treatment is delivered.
General advice
When interacting with patients in remote/
distant settings or patients that have recently 
travelled, a detailed recent travel history, 
including prophylaxis and vaccinations should 
form part of the paramedic history taking in 
anyone with a suspected travel related illness. 
In patients that have travelled recently, you may 
be unfamiliar with diseases present in those 
areas. Your patient may have knowledge regard-
ing diseases they were warned about before or 
during their travels and the CDC and WHO 
websites are a great resource to search current 
warnings and pathogens to be aware of based 
on location.
In general, any fever in the returned traveller 
should be taken seriously and further investi-
gated. Always take PPE precautions to protect 
yourself and your patient and to prevent spread 
of disease between colleagues, healthcare staff 
and patients. You may have a wide range of 
working differentials and may be left treating 
symptoms as they appear; often many tests will 
need to performed and depending on incuba-
tion periods they may come back negative at 
first even if the patient is infected.
Infant mortality from many of these diseases 
is high – a child dies from malaria every two 
minutes for example – and children should 
always be triaged and treated immediately. [5] 
When working overseas or in areas with high 
rates of disease, patient education is a great way 
to reduce or prevent the acquisition or spread 
of many diseases. Knowing how a disease is 
contracted and how it is spread is useful infor-
mation that can be passed on to the local popula-
tion. Lastly, never feel discouraged to ask for help 
and use your colleagues and others as resources!
Malaria
Background & incidence
Human malaria is caused by four species 
of parasitic protozoa, Plasmodium falciparum, 
Plasmodium vivax, Plasmodium ovale, and 
Plasmodium malariae, which are transmitted by 
Anopheles mosquitoes (vector). It is endemic 
throughout tropical areas of the world, infect-
ing at least 200 to 500 million people annually 
in 91 countries, and resulting in 1 to 2 million 
deaths. P. falciparum is the most severe and life 
threatening type of malaria.[5]
This disease is preventable and curable as 
long as it is recognized and treated effectively. 
Africa has the highest rate of malaria, with 
almost 90% of reported cases and 92% of all 
malaria deaths from this area.[5] Other areas 
that are at risk of malaria are South-east Asia, 
Latin America and the Middle East. With 
increased awareness and prevention rates of 
malaria and malaria caused deaths are slowly 
decreasing. In the areas with high rates of trans-
mission, approximately 70% of malaria caused 
deaths are in children under 5 years of age as 
they are highly susceptible to infection and 
illness.[5] However, there is some good news: 
between 2000 and 2015, malaria incidence rates 
(new malaria cases) fell by 37 % globally, and by 
42 % in Africa.[6]
Transmission
Transmission occurs through the bites of 
female Anopheles mosquitos between dusk 
and dawn. Intensity of transmission depends 
on the parasite, the vector, the human host 
and the environment. The parasite is found 
in red blood cells, thus it can be transmitted 
through blood transfusions, organ transplants, 
shared needles/syringes or intrauterine. Malaria 
cannot be spread human to human through 
personal contact. Groups who are most at risk 
are: infants, children under 5 years, pregnant 
women, people with HIV/AIDS, immigrants, 
mobile populations and travellers. Fortunately 
in many locations the risks of malaria are only 
seasonal. The best way to diagnose malaria 
is through blood smears, although there are 
dipstick antigen tests available.
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Prevention
Prevention of malaria transmission is a high 
priority. If travelling to a setting with a high 
incidence of malaria, travellers should consult 
their doctor four to six weeks prior to travel-
ing for required inoculations and prescription 
of antimalarial drugs as preventative measures. 
A vaccine is currently available against Plasmo-
dium falciparum malaria.[7] Many people who 
live in areas with high rates of malaria often 
have some acquired immunity due to increased 
exposure; though they still may become 
infected, this exposure may prevent them from 
becoming severely ill. Pregnant women should 
avoid travelling to high risk areas as malarial 
infections can cause pregnancy issues such as 
premature delivery, miscarriages or stillbirths. 
Fortunately, many drugs used to treat malaria 
are safe to consume if pregnant. 
The best way to prevent malaria trans-
mission is to prevent mosquito bites – this is 
known as vector control. This can be done by 
using insect repellents, avoid being outside 
between dusk and dawn (most disease trans-
mitting vectors are active during this period), 
wearing long sleeved clothing at night, use of 
insecticide treated mosquito nets and perform-
ing indoor residual spraying.
Signs & symptoms
Typical signs and symptoms are fever 
and flu like symptoms. Patients often present 
with chills, headache, muscle aches or fatigue. 
Nausea, vomiting, and diarrhea may be present 
and patients may be anemic or jaundiced. 
Patients may not always have the typical malar-
ial paroxysms of fever and chills, and instead 
they may present with nonspecific symptoms 
such as fatigue, diarrhoea, headache, myalgia, 
or sore throat. If the infection is not treated, 
malaria can progress to renal failure, confusion, 
seizures, coma or death. Signs and symptoms 
usually will begin to occur anywhere from 10 
days to 4 weeks after infection but can be as late 
as 1 year post infection.
Management
Prehospital care priorities for the patient 
with malaria include correction of dehydra-
tion, pyrexia, hypoglycemia, and acidosis. 
Patients may present in respiratory distress 
due to metabolic acidosis, severe anemia and 
severe lung infections due to decreased immune 
function. Chloroquine is the drug of choice for 
infections with chloroquine-susceptible malar-
ial parasites. Chloroquine-resistant P. vivax 
infections can be treated with quinine or quini-
dine in conjunction with doxycycline.
Tuberculosis
Background & incidence
Tuberculosis (TB) is caused by a bacterial 
infection with Mycobacterium tuberculosis. 
Annually, approximately 8.7 million people are 
infected with TB worldwide, many who remain 
asymptomatic. The infection can lie dormant 
in infected persons for many years, and can 
reactivate during periods of stress or immuno-
suppression. Pulmonary infection is the most 
common presentation, however, patients can 
present with extrapulmonary TB infection in 
areas such as the lymph nodes, kidneys, pericar-
dium and meninges.
Transmission
TB is spread through airborne transmission 
from someone infected and sick. A diseased 
person can spread the bacteria through cough-
ing, sneezing or singing and usually only those 
in close contact are at risk. TB cannot be spread 
by shaking hands, sharing food/drink, touching 
clothing/fabrics or by kissing. It is possible to 
come into contact with TB without becoming 
symptomatic (latent infection). Some patients 
can become unwell weeks, months or even years 
later when immunocompromised.
If exposed, it is common to have symptoms 
occur between 2-12 weeks after exposure and if 
a patient has a latent infection they are at the 
highest risk of it progressing to an infection 
within the first few years. It is recommended 
to have latent infections treated. At risk groups 
for infection include those who have had close 
contact with an infected person, immigrants 
from places with high rates of TB, groups 
of people with increased transmission rates 
(homeless, IV drug users and those with HIV) 
and people who work closely with groups of 
people that have an increased transmission rates 
(hospitals, shelters, prisons, nursing homes). 
Those who are at risk of being immunocompro-
mised such as those with comorbidities, receiv-
ing chemotherapy or taking certain medica-
tions are also at an increased risk.
Signs & symptoms
Common signs and symptoms of pulmo-
nary TB include a cough persisting for over 
three weeks, which may be productive (blood or 
sputum), and may be associated with chest pain, 
weakness, fatigue and weight loss (often due to 
loss of appetite). Often, the patient will have a 
fever, accompanied by chills and night sweats. 
Extrapulmonary TB symptoms depend on the 
organs or system affected.
Provider safety
The use of PPE or respiratory devices is 
recommended such as a properly fitted N95 
mask. Providers should have a TB test conducted 
before travelling, and again 8-10 weeks after 
returning. Avoid areas of poor ventilation 
or with recirculation of air. As a health care 
provider if you are providing care for someone 
who is infected or possibly infected with TB it 
is recommended to separate them from other 
patients if possible. Collect a thorough history 
of possible TB exposure/infection, identify any 
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their medical history for conditions that may 
put them at an increased risk of infection.
If you are managing a patient’s airway 
ensure you wear eye protection and a face shield 
and if intubation is required, attach a bacterial 
filter to the ETT. Ensure there is increased 
ventilation in the ambulance or clinic and have 
as much outdoor airflow through as possi-
ble. Inform receiving hospitals of the patient’s 
disease or possible infection; hospitals may 
have an AII (airborne infection isolation) room 
to adequately isolate the patient. Most impor-
tantly ensure to adequately disinfect hands, 
equipment and ambulance between all patients.
Management
There are multiple treatment options for TB, 
selection of an appropriate agent varies based on 
whether it is a latent infection, active infection, a 
patient who also has HIV, or a pregnant patient 
or a child. The treatment options of an antimi-
crobial or a combination of antimicrobials will be 
administered over a 6-9 month period.
HIV and AIDS
Background & Incidence
The Human Immunodeficiency Virus 
(HIV) is a retrovirus that attacks the body’s 
immune system, specifically CD4 T cells, 
weakening the body’s ability to fight off infec-
tions and some types of cancers. As the infec-
tion continues to destroy and impair immune 
function, individuals become immunodefi-
cient. If HIV is left untreated it leads to the 
development of Acquired Immunodeficiency 
Syndrome (AIDS), the most advanced stage 
of HIV infection, defined by the development 
of infections and some cancers. Once infected 
with HIV individuals carry it for life.
The WHO estimates that there are 30.8 – 
42.9 million individuals living with HIV in 
2016, with 1.6 – 2.1 million new infection that 
year. They report 800,000 – 1.2 million deaths 
as a result of AIDS in 2016.8
Transmission
HIV is spread through mucus membrane 
or open tissue contact with bodily fluids such 
as blood, semen, genital fluids or breast milk. 
The majority of new infections are due to sexual 
intercourse or shared needles/syringes. HIV can 
be transmitted through accidental needle sticks 
or exposure to infectious materials or any fluid 
with visible blood. There is no evidence that 
HIV can be spread through normal day to day 
contact or through infected food or water.[8,9] 
Signs & Symptoms
Signs and symptoms of HIV will vary 
depending on the stage of infection and can 
vary from person to person. The early stages of 
HIV often present with either no symptoms or 
flu like symptoms and occur between 2-4 weeks 
after infection. As the infection progresses 
the individual may develop weight loss, fever, 
diarrhea or coughs. Without treatment the 
individual may develop severe infections and 
cancers.[8,9]
Provider Safety
There is minimal risk of occupation exposure 
to paramedics from the HIV virus. Standard 
precautions are acceptable and no additional or 
special PPE are required. Even with exposure to 
bodily fluids, the risk from a direct contact infec-
tion to a non-mucous membrane is believed to 
be near zero. The largest risk is through needle-
stick or other sharp object injuries, although this 
is estimated to be less than 1%.9,10 Paramed-
ics should ensure proper sharps safety at all 
times with increased vigilance when caring for 
patients with the HIV infection. If an exposure 
is suspected the CDC recommends immediate 
treatment with antiviral therapies.[10]
Management
Treatment and management of a patient 
with HIV/AIDS is directed at treating oppor-
tunistic infections and cancer, managing their 
antiretroviral therapy and ensuring a healthy 
lifestyle. Patients are often on multiple medica-
tions to combat the virus in multiple ways. 
There can be many side effects associated 
with taking multiple medications daily such 
as nausea, vomiting, diarrhea, cardiac disease, 
bone loss, rhabdomyolysis, hyperlipidemia and 
hyperglycemia.[8,9] Paramedics should focus 
on symptom management as they arise.
Additionally, if working in a remote setting, 
paramedics should focus on preventative strat-
egies. Education should focus on high risk 
groups and activities such as condom use during 
sexual intercourse, harm reduction for IV drug 
users, and promotion of HIV testing.
Cholera
Background & incidence
Cholera is a severe form of secretory diarrhea 
caused by the bacterium Vibrio cholera which 
can lead to severe dehydration. Originally found 
in the sub-Indian continents, cholera spread to 
Europe in the 1800s and today is endemic in a 
number of regions throughout the world.[11] 
The WHO estimates that there are between 
1.3 and 4.0 million cases of cholera annually 
accounting for between 21,000 and 143,000 
deaths.[12] Contracted through consumption 
of infected food and water, epidemics are often 
linked to natural disasters and humanitarian 
aid missions such as the 2010 earthquake Haiti, 
and the 2016-2017 Yemen outbreak.
Symptoms and signs
Symptoms can occur within a few hours up 
to five days post infection and during epidem-
ics affects both children and adults equally. 
The majority of people affected will be asymp-
tomatic or present with mild symptoms easily 
treated with oral rehydration. It is important to 
note that these individuals still shed the virus 
in their stool for up to 10 days post infection. 
Only 5-10% of people that are infected develop 
severe disease.[11]
Cholera diarrhea, sometimes referred to as 
“rice water stools” (as it looks starchy like water 
that has been used to soak rice), is typically 
non-bloody and non-mucoid. This diarrhea can 
cause profound hypotension. Patients typically 
do not report pain and are afebrile but may also 
experience vomiting. As the diarrhea contains 
a number of important electrolytes, various 
metabolic disturbances are possible. Hypoka-
lemia can cause weakness, cardiac arrhyth-
mia and cramping. Hypocalcemia can cause 
muscle tetany and spasms. Hypoglycemia, 
more common in children, can occur rapidly 
and lead to CNS dysfunction including loss 
of consciousness and seizures. Loss of bicar-
bonate and hypoperfusion of tissue can lead 
to a metabolic acidosis. Left untreated, severe 
cholera can be fatal within a few hours.[11,12] 
Secondary complications are typically 
related to dehydration and include stroke, renal 
tubular necrosis, and total circulatory collapse.
Management
For non-severe cholera patients should 
continue eating as usual and the focus should be 
on oral rehydration to replace fluids and electro-
lytes. IV rehydration is not typically recommended 
or necessary.[11] Tetracycline and erythromy-
cin can help shorten the duration and severity 
of diarrhea, reduce the amount of rehydration 
required and shorten the period of time they 
shed the bacteria in their stool. Infants should 
be encouraged to continue breastfeeding. During 
an outbreak, immediate access to rehydration is 
required. Many people will be infected and have 
no symptoms, these people are still shedding the 
bacteria through their feces and can infect others 
for 1 -10 days after infection.
Prevention
As cholera is spread through fecal contam-
inated water, the best way to prevent spread is 
through proper hygiene and education. Short 
term solutions include promoting proper hand 
washing with soap, safe handling and storage 
of food and water, and the appropriate disposal 
of feces. Additionally individuals should be 
instructed to treat any water with an appro-
priate disinfectant (e.g. chlorine). Oral cholera 
vaccines have been shown effective with 60-85% 
prevention over 2-3 years.[14]
Long term solutions for cholera control 
include water treatment facilities (chlorina-
tion), household interventions such as safe 
water storage and water filtration or disinfec-
tion, and safe sewage disposal systems. These 
plans require long term maintenance and 
investments, many of which are unavailable for 
underdeveloped countries. The use of a decen-
tralized sanitation system is possibly a more 
cost effective option for developing countries 
and is effective in cholera prevention.[11]
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Provider Safety
When working in an area during a cholera 
outbreak or with endemic cholera, paramed-
ics need to be vigilant to avoid contact with 
contaminated water or food. It is recom-
mended to only drink bottled or boiled water 
and avoid using ice cubes.[12] Paramed-
ics should practice good hand and personal 
hygiene with frequent hand washing with 
soap and use of hand sanitizer.[11] If it cannot 
be confirmed that safe water is available for 
cooking try to eat packaged foods when possi-
ble. Standard contact precaution PPE is effec-
tive in protecting providers from a cholera 
outbreak. Paramedics should don a gown, 




Yellow fever is a flavivirus that is transmit-
ted by several different mosquito species with 
humans and other non-human primates as the 
primary hosts. Yellow fever is endemic in the 
tropical areas of Africa and South and Central 
America but can create large outbreaks if intro-
duced into the urban environment.[15] Due to 
the non-specific nature of symptoms and the 
variety of clinical severity accurate epidemio-
logical data is difficult to obtain.[15] Estimates 
from the early 1990’s reported approximately 
200,000 cases per annum and over 30,000 fatal-
ities as a result.[15]
Prevention
Prevention is the best form of control for 
yellow fever. As yellow fever is only spread 
through mosquito bites, prevention of these 
bites is essential. The use of insect repellants 
(such as those containing DEET), wearing 
clothing which reduces exposure to bites, perme-
thrin spray can be used on clothing to prevent 
bites, and using mosquito nets while sleeping. 
Immunization should be performed for anyone 
over 9 months who will be living or working in 
an area with a risk for yellow fever.[17,18]
Signs & symptoms
Yellow fever has a 3-6 day incubation 
period. After this time the majority of people 
do not develop any symptoms but remain 
potential hosts for the virus. Those who do 
develop symptoms typically report fever, chills, 
headache, widespread myalgia, and conjunc-
tival congestion.[17] After several days, the 
majority of patients recover with no long term 
consequences. A small number of patients may 
develop a life-threatening illness with increas-
ing fever, jaundice, renal failure and profuse 
bleeding (due to thrombocytopenia and coagu-
lopathy). Bleeding can occur from the mouth, 
nose, eyes, or stomach.[17] Patients can often 
develop bleeding in the feces or vomit. Half 
of the patients who develop these severe 
symptoms will die within 10-14 days, those 
who recover typically have no long term organ 
damage.[17,18,1]
Management
There is no specific treatment for yellow 
fever and providers should focus on symptom 
management.[18] Management of pyrexia, 
hypotension, pain and temperature are key 
priorities in supportive treatment of patients 
with yellow fever. Patients should also be keep 
indoors, ideally under a bug net canopy, to 
prevent further mosquito bites for the first few 
days of the patient’s illness.[17,18] NSAIDS 
and ASA should be avoided as they increase 
the risk of bleeding.
Provider Safety
There are no additional PPE requirements 
when working with a patient with yellow 
fever and standard precautions are accept-
able. Care should be taken to follow standard 
prevention steps for mosquito borne illnesses 




Tetanus is an infection caused by the spores 
of the bacterium Clostridium tetani which 
enters the body through open skin and affects 
the nervous system of subjects infected and can 
be fatal. The bacteria is found naturally in the soil 
and effects individuals of all ages. The bacteria 
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produces a toxin called tetanospasmin which 
effects motor neurons. Tetanus is classified into 
4 categories: generalized, localized, cephalic and 
neonatal tetanus. The last time data was collected 
for the United States there was an estimated 28 
cases of tetanus per year.[19]
Prevention
Tetanus is preventable through vaccination 
and is typically given on a schedule as part of 
a combination vaccine with Diptheria, Tetanus, 
and Pertussis. Doses are given on schedule up 
to the age of 12 years after which a booster 
is recommended every 10 years. Proper hand 
hygiene and cleaning of wounds is important 
for prevention of tetanus.[19]
Signs and Symptoms
From exposure to illness, Tetanus usually 
takes between 3 and 21 days, average of 8 days.
[19] The closer to the central nervous system 
the shorter the incubation period and worse 
prognosis. As discussed previously there are 
four main manifestations of tetanus[19]:
• Local Tetanus:
o A rare form of tetanus that only affects 
the area where the injury occurred. 
Patients experience persistent muscle 
contractions which can last for months. 
Local tetanus is rarely fatal
• Generalized Tetanus:
o The most common form of tetanus. The 
first sign is typically lock jaw, nuchal 
rigidity, dysphagia and facial muscle 
involvement. As the disease progresses 
patients can have generalized muscle 
spasms in response to stimuli such as 
noise or light, these can be extremely 
painful and appear as tonic contractions 
with hyperextended back, extended 
extremities and clenched fists
• Cephalic Tetanus:
o A rare form of tetanus that is associated 
with head trauma or otitis media, it can 
be localized or generalized
• Neonatal Tetanus:
o Rare in North America but is a very 
common cause of death of infants in 
underdeveloped countries. It can occur 
due to an unsanitary delivery, cutting 
of the umbilical cord with contami-
nated instruments and lack of maternal 
immunization. An estimated 49,000 
neonates died from tetanus in 2013 which 
is significantly lower than the 180,000 
in 2002 but it is still a large concern in 
underdeveloped countries. In the United 
States, there are reportedly only 30 cases 
a year. Symptoms are similar to those of 
generalized tetanus
Complications of tetanus include laryngo-
spasm or spasm of respiratory muscles which 
can cause respiratory distress or respiratory 
arrest. Additionally, sustained contractions or 
convulsions can cause fractures of the spinal 
column or long bones. Hyper-reactivity of 
the autonomic nervous system can lead to 
dysrhythmias and hypertension.[19]
Management
All wounds should be cleaned and any 
necrotic tissue should be removed. If the 
patient is showing signs of tetanic spasms 
special attention should be paid to maintain-
ing the patient’s airway. Treatment with 
human tetanus immunoglobulin (TIG) is 
recommended for both children and adults. 
TIG works to remove any tetanus toxin that 
is unbound to nerve endings. Seizure control 
and control of muscle spasms through medica-
tions such as benzodiazepines are indicated. 
Magnesium sulfate and beta blockers are 
sometimes used to help control involuntary 
muscle spasms as well as heart rate and respi-
rations.[19]
Provider Safety
Tetanus is not transmitted from person-to-
person and therefore there is not an increased 
risk when working with patients with tetanus.
[19] Vaccination and proper hygiene remain 
essential for prevention of tetanus.  
Resources
WHO Tropical Diseases: http://www.who.int/topics/tropical_diseases/
en/
CDC: https://wwwnc.cdc.gov/travel/ 
Specialist education in the area of tropical medicine exists for 
paramedics through courses such as the Tropical, Travel and 
Expedition Medical Skills course offered by the College of Remote 
and Offshore Medicine, and the Remote Advanced Medic Program 
offered by the Institute for Health Professionals at Portland Community 
College. In addition, there are several free online education courses 
available that address topics in this area of practice. 
Disclaimer
The views and opinions expressed in this 
article are those of the authors and do not 
necessarily reflect the official policy or position 
of their employers or organisations.
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